Mechanism of Action and Main Effects
Pharmacological support for patients with threatened miscarriage is based on specialized hormonal agents. The primary goal of such therapy is the medical suppression of excessive uterine muscle activity.
Drugs in this group specifically cause a reduction in myometrial excitability and contractility. This therapeutic effect is achieved through a specific pharmacodynamic mechanism: the active components of the drugs provide a marked attenuation of the physiological effects of oxytocin. Because oxytocin is a potent natural stimulator of uterine contractions, suppressing its influence helps to relieve hypertonus and prevent premature expulsion of the conceptus or fetus.
Combined Oral Agents
This group includes the combination of ethinyl estradiol and acetomepregenol. This fixed combination of active substances is widely used in gynecological and obstetric practice.
Dosage Form: The drug is produced in a solid dosage form as tablets intended for oral administration (per os route).
Indications for Prescription: The range of applications for the tablets covers several conditions:
- Obstetric practice: treatment of recurrent miscarriages, as well as threatened miscarriages. Notably, use for this purpose is restricted exclusively to the first trimester of pregnancy.
- Gynecological practice: correction of diagnosed menstrual cycle disorders.
- Family planning: use of the combination as a reliable contraceptive method.
Side Effects: Taking the tablet form may be accompanied by several adverse reactions in the patient. The most typical side effects include nausea, intermittent headache, and breast tenderness or engorgement.
Injectable Progestogens
A prominent representative of injectable hormonal therapy is hydroxyprogesterone (Hydroxyprogesteronum). It differs in pharmacological characteristics and indications from its oral tablet analogs.
Dosage Form: The medication is available exclusively as an oily solution for injection. In clinical practice, it is important not to confuse this form with intravenous infusion solutions, vaginal suppositories, or tablets—hydroxyprogesterone is administered intramuscularly as an oil depot, ensuring prolonged action.
Indications for Use:
- In obstetrics: the drug is indicated for recurrent and threatened miscarriages. Unlike oral combinations, its use is justified throughout the first half of pregnancy.
- In oncology: the oily solution of hydroxyprogesterone is included in complex treatment regimens for malignant neoplasms, specifically uterine cancer and breast cancer.
Contraindications: A key limitation to using this oily solution is the development of marked tachycardia immediately upon drug administration. If this adverse reaction is observed, further injections must be discontinued.
Comparative Characteristics of Drugs
To master the topic and correctly choose patient management tactics, it is necessary to clearly differentiate the characteristics of the two agents discussed. Below is a summary table reflecting the main differences in dosage forms, timing of use, and safety profiles.
| Comparison Criterion | Ethinyl estradiol + acetomepregenol | Hydroxyprogesterone |
|---|---|---|
| Dosage Form | Oral tablets | Oily solution for injection |
| Pregnancy Maintenance Timing | Strictly 1st trimester | First half of pregnancy |
| Non-Obstetric Indications | Contraception, menstrual disorders | Oncology (uterine cancer, breast cancer) |
| Specific Side Effects and Risks | Nausea, headache, breast tenderness | Risk of marked tachycardia upon injection |